Nanjing Biopharmaceutical Industry Innovation and Transformation Center was inaugurated at the Nanjing Biopharmaceutical Innovation and Transformation Service Conference that was kicked off on Tuesday.
150 representatives of well-known universities, hospitals, scientific research and clinical trial institutions, multinational biopharmaceutical companies and about 6,000 online guests from home and abroad attended the conference to discuss the path of innovation in the life and health industry.
Nanjing Biopharmaceutical Industry Innovation and Transformation Center will connect with R&D institutions, innovative enterprises, research hospitals and clinical research service institutions through the leading PI workstation and the digital platform for clinical trials, and provide enterprises with one-stop innovation and transformation services covering the full cycle of clinical trials, including clinical trial project review and policy research consultation.
[voice over] Nanjing Clinical Research Ethics Collaborative Review Platform was also launched on Tuesday. Being the first of its kind in the Yangtze River Delta, the regional ethical collaborative review digital platform will help to accelerate the efficient transformation of biomedicine enterprises.
The government of Gulou District of Nanjing also signed the "Co-construction Framework of Wutai Mountain Life and Health Center" with Nanjing Medical University, Nanjing University of Traditional Chinese Medicine, Provincial People's Hospital, Nanjing Medical University Affiliated Brain Hospital, Jiangsu Medical Association, and Nanjing Biomedical Industry Innovation and Transformation Center.
